Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Alliance Forms With Goal Of Boosting Agency Appropriations

This article was originally published in The Gray Sheet

Executive Summary

A group of patient advocates and consultants is creating an organization called the FDA Alliance to advocate for a general increase in federal funding for the agency

You may also be interested in...



Former HHS Chiefs Lead Fight For Bigger FDA Budget

Three former HHS secretaries joined industry, consumer and patient advocacy groups Sept. 25 to launch an early effort to increase appropriations for FDA in fiscal year 2008

Former HHS Chiefs Lead Fight For Bigger FDA Budget

Three former HHS secretaries joined industry, consumer and patient advocacy groups Sept. 25 to launch an early effort to increase appropriations for FDA in fiscal year 2008

FDA Budget Request Proposes New User Fee For Facility Reinspections

FDA is proposing a new mandatory user fee that would require device and drug manufacturers to pay for reinspections of manufacturing facilities cited for violations

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel